The effects of biofeedback in diabetes and essential hypertension

Cleveland Clinic Journal of Medicine

Volumn 77, Issue SUPPL. 3, 2010, Pages

  McGrady, Angele ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; DEPRESSION; DIABETES MELLITUS; HUMAN; HYPERTENSION; LIFESTYLE; METABOLIC SYNDROME X; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOPHYSIOLOGY; RELAXATION TRAINING; REVIEW; RISK FACTOR;

ANXIETY; BIOFEEDBACK, PSYCHOLOGY; DEPRESSION; DIABETES MELLITUS; HUMANS; HYPERTENSION; LIFE STYLE; METABOLIC SYNDROME X; RELAXATION THERAPY; RISK FACTORS;

EID: 77954701734     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.77.s3.12     Document Type: Review

References (41)

1. Centers for Disease Control and Prevention. Prevalence of overweight and obesity among adults: United States, 2003-2004. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/nchs/products/pubs/pubd/hestats/overweight/overwghtadult_03.htm. Accessed August 11, 2009.
2. Mayer-Davis EJ. Type 2 diabetes in youth: epidemiology and current research toward prevention and treatment. J Am Diet Assoc 2008; 108(4 suppl 1):S45-S51.
3. Groop L. Genetics of the metabolic syndrome. Br J Nutr 2000; 83(suppl 1):S39-S48.
4. Pasquali R, Vicennati V. Activity of the hypothalamic-pituitary-adrenal axis in different obesity phenotypes. Int J Obes Relat Metab 2000; 24(suppl 2):S47-S49.
5. Chandola T, Brunner E, Marmot, M. Chronic stress at work and the metabolic syndrome: prospective study. BMJ 2006; 332:521-525.
6. Jonas BS, Lando JF. Negative affect as a prospective risk factor for hypertension. Psychosom Med 2000; 62:188-196.
7. McGrady A, Bourey R, Bailey B. The metabolic syndrome: obe-sity, type 2 diabetes, hypertension, and hyperlipidemia. In: Moss D, McGrady A, Davies TC, Wickramasekera I, eds. Handbook of Mind-Body Medicine for Primary Care. Thousand Oaks, CA: Sage Publications; 2003:275-297.
8. Branth S, Ronquist G, Stridsberg M, et al. Development of abdom inal fat and incipient metabolic syndrome in young healthy men exposed to long-term stress. Nutr Metab Cardiovasc Dis 2007; 17:427-435.
9. Ganong WF. Review of Medical Physiology. 22nd ed. New York, NY: Lange Medical; 2005.
10. McGrady A. Psychophysiological foundations of the mind-body therapies. In: Moss D, McGrady A, Davies TC, Wickramasekera I, eds. Handbook of Mind-Body Medicine for Primary Care. Thousand Oaks, CA: Sage Publications; 2003:43-56.
11. McEwen B. The End of Stress As We Know It. Washington, DC: Joseph Henry Press; 2002.
12. Goldbacher EM, Matthews KA. Are psychological characteristics related to risk of the metabolic syndrome? A review of the literature. Ann Behav Med 2007; 34:240-252.
13. Hughes JW, Stoney CM. Depressed mood is related to high-frequency heart rate variability during stressors. Psychosom Med 2000; 62:796-803.
14. Brook RD, Julius S. Autonomic imbalance, hypertension, and cardiovascular risk. Am J Hypertens 2000; 13(6 Pt 2):112S-122S.
15. Knutson KL, Van Cauter E. Associations between sleep loss and increased risk of obesity and diabetes. Ann N Y Acad Sci 2008; 1129:287-304.
16. Linden W, Klassen K, Phillips M. Can psychological factors account for a lack of nocturnal blood pressure dipping? Ann Behav Med 2008; 36:253-258.
17. Fisher EB, Thorpe CT, DeVellis BM, DeVellis RF. Healthy coping, negative emotions, and diabetes management: a systematic review and appraisal. Diabetes Educ 2007; 33:1080-1103.
18. Vitaliano PP, Scanlan JM, Zhang J, Savage MV, Hirsch IB, Siegler IC. A path model of chronic stress, the metabolic syndrome, and coronary heart disease. Psychosom Med 2002; 64:418-435.
19. Flaa A, Aksnes TA, Kjeldsen SE, Eide I, Rostrup M. Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study. Metab Clin Exp 2008; 57:1422-1427.
20. American Diabetes Association. Standards of medical care in diabetes-2009. Diabetes Care 2009; 32(suppl 1):S13-S61.
21. McGinnis R, McGrady A, Cox S, Grower-Dowling K. Biofeed-back-assisted relaxation in type 2 diabetes mellitus. Diabetes Care 2005; 28:2145-2149.
22. Beck AT. Beck Depression Inventory. San Antonio, TX: Harcourt Brace & Co; 1978.
23. Rice BI, Schindler JV. Effect of thermal biofeedback-assisted relaxation training on blood circulation in the lower extremities of a population with diabetes. Diabetes Care 1992; 15:853-859.
24. Fiero PL, Galper DI, Cox DJ, Phillips LH, Fryburg DA. Thermal biofeedback and lower extremity blood flow in adults with diabetes: is neuropathy a limiting factor? Appl Psychophysiol Biofeedback 2003; 28:193-203.
25. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572.
26. Linden W, Lenz JW, Con AH. Individualized stress management for primary hypertension: a randomized trial. Arch Intern Med 2001; 161:1071-1080.
27. Yucha CB, Clark L, Smith M, Uris P, LaFleur B, Duval S. The effect of biofeedback in hypertension. Appl Nurs Res 2001; 14:29-35.
28. Elliott W, Izzo J Jr, White WB, et al. Graded blood pressure reduction in hypertensive outpatients associated with use of a device to assist with slow breathing. J Clin Hypertens 2004; 6:553-559.
29. Schein M, Gavish B, Herz M, et al. Treating hypertension with a device that slows and regularizes breathing: a randomized double-blind controlled study. J Hum Hypertens 2001; 15:271-278.
30. Giannattasio C, Failla M, Meles E, Gentile G, Grappiolo A, Mancia G. Efficacy of self-treatment of hypertension at home with device-guided breathing. Am J Hypertens 2002; 15(4 Pt 2):186A. Abstract P-425.
31. Schneider RH, Alexander CN, Staggers F, et al. Long-term effects of stress reduction on mortality in persons ≥ 55 years of age with systemic hypertension. Am J Cardiol 2005; 95:1060-1064.
32. Paul-Labrador M, Polk D, Dwyer JH, et al. Effects of randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease. Arch Intern Med 2006; 166:1218-1224.
33. McCraty R, Atkinson M, Tomasino D. Impact of a workplace stress reduction program on blood pressure and emotional health in hypertensive employees. J Altern Complement Med 2003; 9:355-369.
34. Rainforth MV, Schneider RH, Nidich SI, Gaylord-King C, Salerno JW, Anderson JW. Stress reduction programs in patients with elevated blood pressure: a systematic review and meta-analysis. Curr Hypertens Rep 2007; 9:520-528.
35. Nakao M, Yano E, Nomura S, Kuboki T. Blood pressure lowering effects of biofeedback treatment in hypertension: a meta-analysis of randomized controlled trials. Hypertens Res 2003; 26:37-46.
36. Linden W, Chambers LA. Clinical effectiveness of non-drug therapies for hypertension: a meta-analysis. Ann Behav Med 1994; 16:35-45.
37. McGrady AV, Linden W. Biobehavioral treatments of essential hypertension. In: Schwartz M, Andrasik F, eds. Biofeedback: A Practitioner's Guide. New York, NY: Guilford Press; 2003:382-408.
38. Lehrer P. Biofeedback training to increase heart rate variability. In: Lehrer P, Woolfolk R, Sime W III, eds. Principles and Practice of Stress Management. New York, NY: Guilford Press; 2007:227-248.
39. McGrady AV, Higgins JT Jr. Prediction of response to biofeedback- assisted relaxation in hypertensives: development of a hypertensive predictor file (HYPP). Psychosom Med 1989; 51:277-284.
40. Yucha CB, Tsai PS, Calderson KS, Tian L. Biofeedback-assisted relaxation training for essential hypertension: who is most likely to benefit? J Cardiovasc Nurs 2005; 20:198-205.
41. Miller WR, Rollnick S. Motivational Interviewing. 2nd ed. New York, NY: Guilford Press; 2002.